Logo image of ALQGC.PA

QUANTUM GENOMICS SAS-REGR (ALQGC.PA) Stock Price, Quote, News and Overview

EPA:ALQGC - Euronext Paris - Matif - FR0011648971 - Common Stock - Currency: EUR

0.0721  0 (-1.77%)

ALQGC.PA Quote, Performance and Key Statistics

QUANTUM GENOMICS SAS-REGR

EPA:ALQGC (10/24/2024, 7:00:00 PM)

0.0721

0 (-1.77%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High0.16
52 Week Low0
Market Cap5.00M
Shares69.34M
Float57.44M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE0.02
Earnings (Next)N/A N/A
IPO07-28 2009-07-28


ALQGC.PA short term performance overview.The bars show the price performance of ALQGC.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150

ALQGC.PA long term performance overview.The bars show the price performance of ALQGC.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ALQGC.PA is 0.0721 EUR. In the past month the price increased by 175.19%. In the past year, price decreased by -23.78%.

QUANTUM GENOMICS SAS-REGR / ALQGC Daily stock chart

ALQGC.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 20.53 343.18B
1ABBV.MI ABBVIE INC 20.51 342.83B
AMG.DE AMGEN INC 15.79 157.07B
1GILD.MI GILEAD SCIENCES INC 25.31 135.91B
GIS.DE GILEAD SCIENCES INC 24.78 133.10B
VX1.DE VERTEX PHARMACEUTICALS INC 1674.07 116.12B
ARGX.BR ARGENX SE 259.28 35.13B
22UA.DE BIONTECH SE-ADR N/A 24.96B
IDP.DE BIOGEN INC 8.67 19.45B
0QF.DE MODERNA INC N/A 12.31B
1MRNA.MI MODERNA INC N/A 12.31B
GLPG.AS GALAPAGOS NV 7.87 1.62B

About ALQGC.PA

Company Profile

ALQGC logo image Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. The company is headquartered in Paris, Ile-De-France and currently employs 3 full-time employees. The company went IPO on 2009-07-28. The firm is a biopharmaceutical company dedicated to developing new therapies for unmet medical needs in cardiovascular disease, including high blood pressure and heart failure. Its main activity is in research and development of new therapies for the treatment of hypertension, BAPAI (Brain Aminopeptidase A Inhibitors) oriented in the field of cardiovascular diseases, especially high blood pressure and heart failure. The firm also co-develops products with academic teams, biotechnological research entities, and some of the pharmaceutical and bio-science companies. The firm is involved in four research programs. Quantum Genomics also collaborates with Center for Clinical Investigation 9201 APHP / INSERM of the Georges Pompidou European Hospital in Paris, among others.

Company Info

QUANTUM GENOMICS SAS-REGR

33 rue Marbeuf

Paris ILE-DE-FRANCE FR

Employees: 3

Company Website: https://quantum-genomics.com/

Phone: 33185347770

QUANTUM GENOMICS SAS-REGR / ALQGC.PA FAQ

What is the stock price of QUANTUM GENOMICS SAS-REGR today?

The current stock price of ALQGC.PA is 0.0721 EUR. The price decreased by -1.77% in the last trading session.


What is the ticker symbol for QUANTUM GENOMICS SAS-REGR stock?

The exchange symbol of QUANTUM GENOMICS SAS-REGR is ALQGC and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALQGC.PA stock listed?

ALQGC.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for QUANTUM GENOMICS SAS-REGR stock?

7 analysts have analysed ALQGC.PA and the average price target is 10.2 EUR. This implies a price increase of 14047.02% is expected in the next year compared to the current price of 0.0721. Check the QUANTUM GENOMICS SAS-REGR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is QUANTUM GENOMICS SAS-REGR worth?

QUANTUM GENOMICS SAS-REGR (ALQGC.PA) has a market capitalization of 5.00M EUR. This makes ALQGC.PA a Nano Cap stock.


How many employees does QUANTUM GENOMICS SAS-REGR have?

QUANTUM GENOMICS SAS-REGR (ALQGC.PA) currently has 3 employees.


What are the support and resistance levels for QUANTUM GENOMICS SAS-REGR (ALQGC.PA) stock?

QUANTUM GENOMICS SAS-REGR (ALQGC.PA) has a support level at 0.06 and a resistance level at 0.08. Check the full technical report for a detailed analysis of ALQGC.PA support and resistance levels.


Is QUANTUM GENOMICS SAS-REGR (ALQGC.PA) expected to grow?

The Revenue of QUANTUM GENOMICS SAS-REGR (ALQGC.PA) is expected to grow by 1744.53% in the next year. Check the estimates tab for more information on the ALQGC.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy QUANTUM GENOMICS SAS-REGR (ALQGC.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QUANTUM GENOMICS SAS-REGR (ALQGC.PA) stock pay dividends?

ALQGC.PA does not pay a dividend.


What is the Price/Earnings (PE) ratio of QUANTUM GENOMICS SAS-REGR (ALQGC.PA)?

QUANTUM GENOMICS SAS-REGR (ALQGC.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).


ALQGC.PA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to ALQGC.PA. When comparing the yearly performance of all stocks, ALQGC.PA is a bad performer in the overall market: 93.91% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ALQGC.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ALQGC.PA. Both the profitability and financial health of ALQGC.PA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALQGC.PA Financial Highlights

Over the last trailing twelve months ALQGC.PA reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS increased by 87.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -84.63%
ROE -726.18%
Debt/Equity 4.49
Chartmill High Growth Momentum
EPS Q2Q%92.58%
Sales Q2Q%N/A
EPS 1Y (TTM)87.28%
Revenue 1Y (TTM)-98.34%

ALQGC.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 34% to ALQGC.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 6121.43% and a revenue growth 1744.53% for ALQGC.PA


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts34.29
Price Target10.2 (14047.02%)
EPS Next Y6121.43%
Revenue Next Year1744.53%